Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest announcement is out from Craneware ( (GB:CRW) ).
Craneware has repurchased 117,395 of its own ordinary shares on the London Stock Exchange between 17 and 22 April 2026 at prices ranging from 1,486p to 1,542p, with a volume‑weighted average price of 1,512.18p. The shares, bought through Berenberg, will be held in treasury, reducing the free float and potentially enhancing earnings per share.
Following these transactions, Craneware now has 34,712,101 ordinary shares in issue excluding treasury, while 830,068 shares are held in treasury and excluded from voting. The updated share count sets the new baseline for investors monitoring their holdings under UK disclosure rules and signals continued execution of the company’s previously announced buyback programme.
Spark’s Take on CRW Stock
According to Spark, TipRanks’ AI Analyst, CRW is a Neutral.
The score is driven primarily by solid financial performance (strong margins and a low-debt balance sheet), but it is meaningfully weighed down by weak technical momentum (price below key moving averages with negative MACD) and a relatively high P/E that limits valuation support despite the dividend yield.
To see Spark’s full report on CRW stock, click here.
More about Craneware
Craneware plc, listed on AIM as CRW.L, is a healthcare technology company specialising in financial and operational performance solutions for hospitals and health systems. Its Trisus cloud ecosystem combines data, revenue and margin intelligence, and advanced analytics to help healthcare organisations optimise performance, improve financial sustainability and support strategic growth.
Average Trading Volume: 256,027
Technical Sentiment Signal: Sell
Current Market Cap: £530.1M
For detailed information about CRW stock, go to TipRanks’ Stock Analysis page.